StockMarketWire.com - Iron deficiency focused Shield Therapeutics said it had appointed James Karis as its new chairman with immediate effect.

Karis had served on the company's board for almost three years and had recently served as chief executive of privately-held MAPI Group.




Story provided by StockMarketWire.com